Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review von Vathiotis, I. A., Syrigos, N. K., Dimakakos, E. P.

Volltext

LYMPHEDEMA DURATION AS A PREDICTIVE FACTOR OF EFFICACY OF COMPLETE DECONGESTIVE THERAPY von Michopoulos, E., Papathanasiou, G., Krousaniotaki, K., Vathiotis, Troupis, T., Dimakakos, E.

Volltext

ESVM Guideline on peripheral arterial disease von Frank, Ulrich, Nikol, Sigrid, Belch, Jill, Boc, Vinko, Brodmann, Marianne, Carpentier, Patrick H, Chraim, Ali, Canning, Caitriona, Dimakakos, Evangelos, Gottsäter, Anders, Heiss, Christian, Mazzolai, Lucia, Madaric, Juraj, Olinic, Dan Mircea, Pécsvárady, Zsolt, Poredoš, Pavel, Quéré, Isabelle, Roztocil, Karel, Stanek, Agata, Vasic, Dragan, Visonà, Adriana, Wautrecht, Jean-Claude, Bulvas, Miroslav, Colgan, Mary-Paula, Dorigo, Walter, Houston, Graeme, Kahan, Thomas, Lawall, Holger, Lindstedt, Isak, Mahe, Guillaume, Martini, Romeo, Pernod, Giles, Przywara, Stanislaw, Righini, Marc, Schlager, Oliver, Terlecki, Piotr

Volltext

PO-69 Evolution of long term use of tinzaparin (12 months) in patients with pulmonary embolism: a prospective study of our clinic von Dimakakos, E, Triadafillou, O, Oikonomopoulos, G, Syrigos, K

Volltext

PO-68 Evolution of long term use of tinzaparin (6 months) in patients with DVT: a prospective study of our clinic von Dimakakos, E, Oikonomopoulos, G, Triadafillou, O, Syrigos, K

Volltext

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vasc... von Gerotziafas, GT, Catalano, M, Colgan, MP, Pecsvarady, Z, Wautrecht, JC, Fazeli, B, Olinic, DM, Farkas, K, Elalamy, I, Falanga, A, Fareed, J, Papageorgiou, C, Arellano, RS, Agathagelou, P, Antic, D, Auad, L, Banfic, L, Bartolomew, JR, Benczur, B, Bernardo, MB, Boccardo, F, Cifkova, R, Cosmi, B, De Marchi, S, Dimakakos, E, Dimopoulos, MA, Dimitrov, G, Durand-Zaleski, I, Edmonds, M, El Nazar, EA, Erer, D, Esponda, OL, Gresele, P, Gschwandtner, M, Gu, YQ, Heinzmann, M, Hamburg, NM, Hamade, A, Jatoi, NA, Karahan, O, Karetova, D, Karplus, T, Klein-Weigel, P, Kolossvary, E, Kozak, M, Lefkou, E, Lessiani, G, Liew, A, Marcoccia, A, Marshang, P, Marakomichelakis, G, Matuska, J, Moraglia, L, Pillon, S, Poredos, P, Prior, M, Salvador, DRK, Schlager, O, Schernthaner, G, Sieron, A, Spaak, J, Spyropoulos, A, Sprynger, M, Suput, D, Stanek, A, Stvrtinova, V, Szuba, A, Tafur, A, Vandreden, P, Vardas, PE, Vasic, D, Vikkula, M, Wennberg, P, Zhai, ZG

Volltext

PO-16 Venous thromboembolism in small cell lung cancer patients: an epidemiological study von Dimakakos, E., Livanios, K., Kainis, E., Vassias, A., Stefanou, D., Kotteas, E., Gerotziafas, G.T., Syrigos, K.

Volltext

PO-24 Lung cancer: the clinical profile of D-dimers von Kokkotou, E., Gkiozos, I., Vassos, D., Karakatsanis, S., Kotteas, E., Gerotziafas, G.T., Syrigos, K., Dimakakos, E.

Volltext

PO-50 The role of the blood factors in the survival of patients with non-small cell lung cancer von Dimakakos, E., Cholidou, K., Mpakakos, P., Anagnostopoulos, N., Gkiozos, I., Syrigos, N., Kotteas, E., Gerotziafas, G.T.

Volltext

PO-62 Tinzaparin: anti-cancer properties? von Dimakakos, E., Vathiotis, J., Toki, M., Charpidou, A., Pantazopoulos, K., Kotteas, E., Syrigos, K.

Volltext

PO-15: Tinzaparin: a safe choice for lung cancer with VTE and renal impairment von Dimakakos, E., Syrigos, K.N., Vathiotis, I., Tsiakos, K., Anagnostakis, M., Grammoustianou, M., Gomatou, G., Sarropoulou, F., Gerotziafas, G., Kotteas, E.

Volltext

PO-40: Therapeutic approaches of superior vena cava syndrome in patients with non-small cell lung cancer (NSCLC) von Dimakakos, E., Grammoustianou, M., Sarropoulou, F., Kouvela, M., Gkiozos, I., Kotteas, E., Gerotziafas, G., Mavroudis, D., Syrigos, K.N.

Volltext

PO-17 Mesothelioma: a retrospective study of thromboembolism events von Dimakakos, E., Basdeki, K., Gkiozos, I., Tsagkouli, S., Rovina, N., Mpakakos, P., Ptohis, N., Trontzas, I., Kotteas, E., Syrigos, K.

Volltext

PO-39: Superior vena cava stenting: an effective and safe therapeutic choice for the treatment of superior vena cava syndrome in lung cancer patients von Grammoustianou, M., Syrigos, K.N., Sarropoulou, F., Patriarcheas, V., Ptohis, N., Charpidou, A., Gkiozos, I., Kouvela, M., Gerotziafas, G., Kainis, El, Kotteas, E., Dimakakos, E.

Volltext

Interstitial magnetic resonance lymphography: the clinical effectiveness of a new method von Dimakakos, E, Koureas, A, Koutoulidis, V, Skiadas, V, Katsenis, K, Arkadopoulos, N, Gouliamos, A, Vlachos, L

Volltext

Emmanuil Kondoleon: pioneer in surgical treatment for lymphedema von Dimakakos, E, Arkadopoulos, N, Katsenis, K, Toumpis, S, Syrigos, K

Volltext

Effect of collagen powder on lymphorrhea after modified radical mastectomy. A randomized controlled trial von Stafyla, V, Dimakakos, E, Koureas, A, Gennatas, K, Voros, D, Vassiliou, I, Smyrniotis, V, Arkadopoulos, N

Volltext

The action of Erythropoietin on venous thromboembolic events in lung cancer patients von Dimakakos, E., Kakavetsi, A., Gkiozos, I., Charpidou, A., Kotteas, I., Boura, P., Ntalakou, E., Syrigos, K.

Volltext

Validation of the Khorana score in lung cancer patients: a new predictor of early mortality? von Vathiotis, I., Dimakakos, E., Boura, P., Ntineri, A., Charpidou, A., Gerotziafas, G.T., Syrigos, K.

Volltext

Small cell lung cancer patients and venous thromboembolism: The need of anticoagulation treatment von Dimakakos, E., Livanios, K., Tsagkouli, S., Tsimboukis, S., Vassos, D., Krommidas, G., Syrigos, K.

Volltext